Integral Diagnostics Ltd. (AU:IDX) has released an update.
Integral Diagnostics Limited reports a 6.6% increase in annual revenues to $469,697,000, despite significant downturns with EBITDA plummeting by 55.2% and a staggering 342.4% decrease in profit after tax, resulting in a loss of $60,699,000 for the fiscal year ended June 30, 2024. The company has declared a fully franked final dividend of 3.3 cents per share, scheduled for payment on October 3, 2024, following an interim dividend of 2.5 cents paid earlier in the year.
For further insights into AU:IDX stock, check out TipRanks’ Stock Analysis page.